They wouldn't get the company for that because we wouldn't allow it. The company also has 2 paths to funding, they may not even end up partnering with pharma.
Ann: Positive AD-214 Phase I extension study results, page-189
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $15.48M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.6¢ | 2.6¢ | $520 | 20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1968532 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 602322 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.5¢ | 2.6¢ | 2.5¢ | 101798 | ||
| Last updated 15.47pm 14/06/2024 ? | |||||
| 1AD (ASX) Chart |